Didactic Speaker

Dr. Caroline S. Blaum is a consultant and former Assistant Vice President at the National Committee for Quality Assurance (NCQA).  She joined NCQA in September 2020 and is closely involved in quality content development and implementation for chronic diseases, complex patients, and home and community-based care.  She leads projects that draw on her previous clinical, administrative and research experience at the intersection of quality measurement, delivery system implementation, and policy relevance. From 2012-2020, Dr. Blaum was the Diane and Arthur Belfer Professor of Geriatric Medicine and Director of the Division of Geriatric Medicine and Palliative Care. At NYU, she maintained an active clinical practice and supervised clinical education for medical trainees in geriatrics and palliative care.  She led an extensive reach research program in translational research that was supported by the NIA, AHRQ, PCORI, and The John A Hartford Foundation concerning models of care for vulnerable populations, multiple chronic conditions, frailty, and diabetes in older adults. She has over 120 peer reviewed papers and chapters. Prior to going to NYU, Dr. Blaum was Professor of Internal Medicine, Geriatric and Palliative Medicine at the University of Michigan, and a Research Scientist at the Ann Arbor VA Geriatrics Research, Education and Clinical Center.  She served as the Assistant Dean for Clinical Affairs at the University of Michigan Medical School, and as an Associate Medical Director of the University of Michigan’s Faculty Group Practice, directing the University of Michigan Health System’s Population Health Program. She led the University of Michigan’s activities related to care delivery innovations such as its Accountable Care Organization (ACO), Patient Centered Medical Home, Advanced Primary Care Medicare Demonstration, and various other initiatives. Dr. Blaum has also served as the Medical Director of a nursing home, a home health agency, and a Medicare Advantage Plan. Dr. Blaum has been active in national policy work and was the founding Chair of the American Geriatrics Society’s (AGS) Quality Performance and Measurement Committee.

Hub Team Faculty

Program Chair

Nicolas Cuttriss, MD, MPH, FAAP

Pediatric Endocrinologist

Founding Director & CEO

ECHO Diabetes Action Network

Hub Team Activity Planners

Abinash P Achrekar, MD, MPH

Former Executive Vice Chair of Medicine

Professor of Medicine

Division of Cardiology

University of New Mexico

Nayan Arora, MD, FASN

Associate Professor of Medicine

Associate Director Nephrology Fellowship Program

Division of Nephrology and Hypertension

Oregon Health and Science University

Phyllisa Deroze, PhD

Founder, Black Diabetic Info

Pompano Beach, FL

Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM 

Clinical Pharmacy Specialist – Endocrinology 

Certified Diabetes Care and Education Specialist 

Boston Medical Center 

Jay H. Shubrook DO FACOFP, FAAFP 

Professor & Diabetologist 

Department of Clinical Sciences & Community Health 

Diabetes Institute 

Touro University California 

Lisa M. Taylor, DNP, MSN, FNP-BC, MPH

Associate Clinical Professor

Director of Diversity, Equity, and Inclusion

University of New Mexico College of Nursing

Boston University Center for Continuing Education Planning Team

Linda Baer, MSPH, CHCP, Associate Director

Michael Burk, BS, Senior Program Manager

Med-IQ Planning Team

Amy Woodward Corum, Grant Development Director

Ali Mayhew, BA, Senior Project Manager

Jaime Symowicz, PhD, Clinical Education and Strategy Manager

Disclosure Policy

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.